I am a breastfeeding mother and i want to know if it is safe to use UNII-V8G4MOF2V9? Is UNII-V8G4MOF2V9 safe for nursing mother and child? Does UNII-V8G4MOF2V9 extracts into breast milk? Does UNII-V8G4MOF2V9 has any long term or short term side effects on infants? Can UNII-V8G4MOF2V9 influence milk supply or can UNII-V8G4MOF2V9 decrease milk supply in lactating mothers?
UNII-V8G4MOF2V9 appears to pass into milk very poorly. Although Australian guidelines recommend against breastfeeding during UNII-V8G4MOF2V9 treatment,[1] these were published before a case report of an infant being safely breastfed by a mother with beta-thalassemia receiving UNII-V8G4MOF2V9 and finding of no drug in breastmilk.[2] If UNII-V8G4MOF2V9 is required by the mother, it is not a reason to discontinue breastfeeding. However, since little published information is available on the use of UNII-V8G4MOF2V9 during breastfeeding, monitoring of the infant's serum iron is recommended.
A woman with beta-thalassemia was started on UNII-V8G4MOF2V9 2250 mg (35 mg/kg) daily immediately postpartum and exclusively breastfed her infant. Blood samples were taken from the infant at 1, 10 and 30 days postpartum. Serum ferritin levels were 190, 218, and 96 mcg/L, respectively (normal range 22-275 mcg/L). Serum iron levels were 101, 77 and 71 mcg/dL, respectively (normal range 60-170 mcg/dL). The infant's growth was normal during the first month at the 41st percentile.[2]
Disclaimer:
Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.